Catalyst Wire Dossier Catalyst Wire Dossier

aflibercept intravitreal injection

aflibercept · Regeneron Pharmaceuticals; Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for aflibercept intravitreal injection, covering 2014-01-10 to 2014-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization [Phase 4]

See pricing